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ABSTRACT
2,3-Dihydro-2-propyl-3-propylimino-9-thioxo-pyrrolo[3,4-b]quinolin-1-one reacts with an aliphatic primary, secondary or
tertiary amine to form a 1:1 substrate:amine (thiolate) complex. It also readily undergoes S-alkylation (with diazomethane or with
an alkyl halide), S-acetylation (with acetic anhydride), hydrogenolysis (Raney nickel) with removal of sulphur, and
acid-catalysed hydrolysis (with selective replacement of the 3-propylimino function by oxygen). Two novel di-(pyrrolo[3,4-b]
quinolinyl) sulphide reaction products are described and their structures established. Treatment of these ‘dimers’ and related
9-alkylthio-substituted pyrroloquinolines with an aliphatic amine provides a convenient access to ‘simple’ or ‘mixed’
2-alkyl-9-alkylamino-3-alkylimino-pyrroloquinoline derivatives. Preliminary antimicrobial (in vitro) tests indicate that: (a) the
weak antimicrobial activity of the aforementioned 9-thioxo-pyrroloquinoline substrate against three selected Gram-positive
pathogens is significantly enhanced in its amine complexes, and by the presence of a 6-fluoro atom in the quinoline moiety,
and (b) that substitution of the 4-oxo-function in 4-oxo-3-quinolinecarboxylic acids by an ethylimino group leads to a marked
reduction in antimicrobial properties.
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6-fluoro-derivatives, antimicrobial activities, di-[(pyrrolo[3,4-b]quinolinyl)] sulphides, 9-alkylthio-substituted pyrrolo[3,4-b]
quinolines.
1. Introduction
The pyrrolo[3,4-b]quinoline ring system is present in
compounds associated with a wide variety of pharmacological
properties as is exemplified with hypnotic1and cytotoxic2 effects,
and with analgesic3 and antiviral4 activities. It is also known5 that
nuclear-substituted 4-thioxoquinolines are significant
antimicrobials. Accordingly, an interest in analogous
pyrroloquinoline structures has arisen from efforts to obtain
new biomedically relevant products.4 In previous contribu-
tions6,7 we showed that aminolysis of 3,3,9-trichloro[3,4-b]
quinolinone 1a offers a convenient and relatively simple meth-
odology to access an assortment of hitherto undocumented
2-alkyl-3-alkylimino-9-thioxo-pyrrolo[3,4-b]quinolines 2, and
related derivatives 3, including amine complexes of 2, namely 4.
Compounds 2 and 4 may be viewed as unusual derivatives of
4-thioxoquinoline 5, and in the light of the aforementioned
observations the question arose as to whether certain of the title
compounds might likewise possess antimicrobial activity. Here
we present further developments in the chemistry and biological
properties in this new area of sulphur-substituted pyrrolo[3,4-b]
quinolines.
2. Results and Discussion
Utilizing a convenient general procedure6, 2-propyl-3-propy-
limino-9-thioxo-pyrroloquinoline 2a was stirred briefly with
excess of diethylamine, triethylamine and tert-butylamine,
respectively, at room temperature, to yield in each case the
appropriate substrate-amine (1:1) complex 4. The latter products
were relatively unstable and tended to decompose at room
temperature on prolonged storage, and more rapidly on heat-
ing. In the mass spectrum the highest m/z value was that of
component 2a. Treatment with dilute acid at room temperature
instantly disrupted 4 to 2a and amine. 1H NMR spectral analysis,
coupled with a quantitative volumetric determination of the
amount of amine present in the complex 4, served to reveal the
latters purity, and to establish a 1:1 substrate:amine composition.
In the absence of a crystal suitable for X-ray study the location
and nature of the bonding between the components in complex
4 was inferred from the following observations: (a) 4-thioxo
quinoline 5 and propylamine formed a comparable (1:1) com-
plex, whereas no similar product resulted from the sulphur-free
pyrroloquinolines 7 and 3a, which was indicative of S being the
focus of bonding in 4; (b) recent X-ray crystallographic studies6 of
2-propyl-3-propylimino-9-thioxo-pyrroloquinoline 2a and
2-propyl-9-thioxo-pyrroloquinoline-1,3-dione 6a located the
enolizable proton in 2a on the 3-propylimino nitrogen atom, and
on the sulphur atom in 6a; such a proton in the course of complex
4 formation is expected to transfer to the more basic nitrogen of
an amine, thereby resulting in a thiolate salt as depicted in 98.
Investigative reactions to gauge the chemical reactivity and
functional group transformations in 2-propyl-3-propylimino-
9-thioxo-pyrroloquinoline 2a and related compounds showed a
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promising potential to access a diversity of pyrrolo[3,4-b]
quinolines derivatives, as is illustrated with the following: Raney
nickel hydrogenolysis at room temperature effected the removal
of the sulphur from 2-propyl-9-thioxo-pyrroloquinoline-
1,3-dione 6 to provide tetrahydro-pyrroloquinoline derivative
10. Alkylation of the sulphur in substrate 2a, and likewise in its
propylamine complex 4a, with either diazomethane or methyl
iodide, gave the 9-methythio-2-propyl-3-propylimino deriva-
tive 8a as was established by a NOE experiment. Acetic anhy-
dride and pyridine readily converted substrate 2a and its com-
plex 4a to the 9-acetylthio-2-propyl-3-propylimino derivative
8d. Treatment of 4 with aqueous acid at room temperature
instantly and quantitatively separated the amine in the complex
to provide component 2, whereas with warm (~50°C) acid the
3-alkylimino moiety in pyrroloquinolines 2, 3, 4, 7 and 8 was
hydrolyzed with production of the corresponding 1,3-dione
derivative 12. This synthetically useful outcome is exemplified
with 9-methylthio 2-propyl-3-propylimino-pyrroloquinoline 8a
and hydrochloric acid at 50°C to give (70%) 9-methylthio-2-
propyl-pyrroloquinoline-1,3-dione 12a, The proposal7 that com-
plex 4a may be formed from 9-chloro-pyrroloquinoline 11 and
hydrogen sulphide in propylamine has now been verified.
Two sulphur-containing products each significantly different
in structure from any of the previously obtained sulphur-
substituted pyrroloquinolines, were isolated in the course of
preparing 4-chloro-N-propyl-9-propylcarbamoyl-3-quinoline
carboxylic acid amide 13 from trichlorothienoquinoline 1a and
propylamine7, and were separated on a silica column. The
1H NMR of one product (m.p. 251–253°C) exhibited signals
(number, multiplicities and chemical shifts) requisite for two
propyl groups and four aromatic protons (total 18 protons),
whereas the HRMS established a molecular formula of
C34H36N6O2S. Such data are compatible with a dimer structure 14,
The 1H NMR of the other product (m.p. 230–232°C) contained
signals for three disparate propyl groups and eight aromatic
protons, whilst the HRMS established a molecular formula
C31H29N5O2S2 according with a structure assignment 15. Assign-
ments 14 and 15 were separately substantiated by unambiguous
synthesis: thus alkylation of 2-propyl-3-propylimino-9-
thioxo-pyrroloquinoline 2a with 9-chloro-2-propyl-3-propyl-
imino-pyrroloquinoline 11 gave (~100%) dimer 14 free of dimer
15, while alkylation of substrate 2a with 9-chloro-2-propyl-
3-thioxo-pyrroloquinoline 16 provided dimer 15 (~100%) also
exclusively. Dimer 14 was unexpectedly produced, in addition
to 2-propyl-3-propylimino-9-thioxo-pyrroloquinoline 2a, on
refluxing complex 4a in toluene9.
Dimer 14 either alone or when together with 15, on stirring
with excess propylamine at room temperature rapidly yielded a
mixture of complex 4a and 9-propylamino-pyrroloquinoline 3a,
indicative of a facile cleavage of the thioether bond in 14/15 (and
of aminolysis of the thioxo function in 15 in an as yet undeter-
mined sequence of events). This observation was extended to
examining the aminolysis of related and representative
9-alkylthio-substituted pyrroloquinolines, viz. 8a, 8b and 8c. The
results (Table 1) confirmed a facile aminolysis with primary
alkylamines and provided a convenient preparation of both
RESEARCH ARTICLE T. van Es, B. Staskun and S. van Vuuren, 75
S. Afr. J. Chem., 2005, 58, 74–81,
<http://journals.sabinet.co.za/sajchem/>.
Table 1 Aminolysis of 9-alkylthio-pyrrolo[3,4-b]quinolines 8.
Amine reactant 9-Alkylamino Product 3
group in 8 (crude) yield, reaction time
n-propylamine methyl, 8a 3a, quantitative, ~30 min
n-propylamine n-propyl, 8b 3a, quantitative, ~15 min
isopropylamine n-propyl, 8b 3b, quantitative, ~20 h
ethylamine n-propyl, 8b 3c, quantitative, ~6 h
n-propylamine phenyl, 8c 3a, quantitative, ~10 min
tert-butylamine n-propyl, 8b no reaction, 24 h
diethylamine n-propyl, 8b no reaction, 65 h
aniline n-propyl, 8b no reaction, 1 week
simple and mixed7 2-alkyl-9-alkylamino-3-alkylimino-substi-
tuted pyrroloquinolines 3. Similar treatment of several represen-
tative non-heteroaromatic substrates, viz. diphenyl sulphide,
methyl 2-(methylthio)benzoate, ethyl 2-(phenylthio)acetate
and 1-phenyl-2-(n-propylthio)ethenone for ~6 h showed no
detectable displacement of the –SR group. It is suggested that
sulphide cleavage in the aforementioned pyrroloquinolines is
effected more readily because of a more effective delocalization
of charge and concomitant resonance stabilization in the pro-
posed intermediate A.
Treating 9-alkylthio-pyrroloquinolines 8 with alkoxide ion
provided the corresponding 9-alkoxy derivative as exemplified
with the 9-methoxy- and 9-propoxy-compounds 8f and 8g.
Compound 8f was also obtained in high yield on refluxing
9-methylthio-pyrroloquinoline 8a in methanol containing
anhydrous sodium acetate (perhaps owing to production of
methoxide ion in situ), and by reacting 9-chloro-pyrrolo
quinoline 11 with sodium methoxide. However, no significant
reaction occurred between 8a and ammonia, and azide-, iodide-,
cyanide- or tert-butoxide ions. The aforementioned 9-alkylthio-
to 9-alkoxy- conversion could be reversed: thus treating 8f with
excess of propylthiolate ion afforded the 9-propylthio-pyrrolo
quinoline 8b. Warming 9-methoxy- and 9-propoxy-pyrrolo
quinolines, viz. 8f and 8g, with aqueous acid, led to hydrolysis of
both 9-alkoxy and 3-propylimino functions in each to yield
pyrroloquinoline-1,3,9-trione derivative 17.
The availability10 of 3,3-dichloro-6-fluoro-thienopyrrolo
[3,4-b]quinolin-1-one 1c prompted an examination of (amongst
others) the fate of the fluorine substituent during aminolysis
with propylamine under the general reaction conditions. In the
event the F remained unaffected, the products being complex 4f
(53%) (formed between equimolar amounts of 6-fluoro-2-
propyl-3-propylimino-9-thioxo-pyrroloquinolinone 2c and
propylamine) and 6-fluoro-2-propylamino-3-propylimino-
pyrroloquinolinone 3d (12%). Separation of the propylamine
from complex 4f was effected with acid to furnish component 2c,
whereas with warm acid the product was the pyrroloquinolin-
1,3-dione 6b (97%).
3.1 Antimicrobial Results
Preliminary Disc Diffusion (DD) and Minimum Inhibitory
Concentration (MIC) studies of the antimicrobial efficacies of
compounds 2 and 4 against three representative Gram-positive
pathogens showed promise. The experimental details (vide in-
fra), and the accumulated outcomes (Table 2) although limited,
allowed for the following tentative inferences and conclusions:
9-thioxo-pyrroloquinolinone 2a exhibited a weak activity
against three representative Gram-positive organisms, S. aureus,
B. cereus and S. epidermidis (Table 2), and did not inhibit the
growth of E. coli; 2a was seemingly a more selective and less
effective antimicrobial than 4-thioxoquinolone 5. It is notewor-
thy and significant, however, that the activity of 2a towards
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the aforementioned Gram-positive organisms was markedly
enhanced (a) when complexed to an aliphatic amine (propyl-
amine, isopropylamine, diethylamine, triethylamine and
tert-butylamine, respectively), as in 4, and (b) when it bore a
6-flouro-substituent, as in 2c. Enhancement (a) is indicated from
comparison of the MIC values (µg mL–1) of 2a with the corre-
sponding ones in its complexes 4a, 4b, 4c, 4d and 4e, while
enhancement (b) is apparent from comparing the MIC values
(against S. aureus) of 2a (78) and its propylamine complex 4a
(19.5) with those of the corresponding 6-fluoro derivatives, viz.
2c (16) and 4f (<13), respectively11. The amine utilized in
complex 4, showed no measurable activity in the DD and MIC
tests.
Table 2 also lists the (disc diffusion) outcomes of in vitro testing
of two recently12 synthesized 1-alkyl-4-alkylimino-1,4-dihydro-
-3-quinolinecarboxylic acids, viz. 18a and 18b, Whereas an exten-
sive literature13 exists devoted to the antimicrobial efficacies of
the ubiquitous 4-oxo-quinolines of type 19, there is little if
any such information available regarding the related 4-imino
analogues 18. The outcomes, albeit very limited, suggest that
replacing the 4-oxo function in 19 by an ethylimino group leads
to a marked diminution in efficacy, at least towards the bacteria
listed. Nevertheless, the 4-iminoquinolines 18 have the potential
to function as prodrugs owing to their susceptibility to alkaline
hydrolysis with production of the active corresponding
4-oxoquinoline 19 (anion)12.
In summary, we have shown that subjecting the title com-
pounds, exemplified by 2a, to, amongst others, Raney nickel
catalysed reduction, acid hydrolysis, and alkylation reactions,
respectively, provides access, in acceptable yields, to a diversity
of hitherto undocumented pyrrolo[3,4-b]quinoline derivatives
suitable for further synthetic procedures and biological testing.
Preliminary results indicate that complexing 2a to an alkylamine
leads to a more effective antimicrobial agent against certain
Gram-positive pathogens.
4. Experimental
For general experimental details and techniques see refs 7 and
12. High-resolution mass spectra (HRMS) were recorded on a
VG 70-SEQ mass spectrometer.1H NMR spectra were recorded
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on a Bruker AC-200 spectrometer (200.13 MHz; in CDCl3 solvent
unless otherwise noted; δ (ppm) values refer to proton chemical
shifts., J values are in Hz). Compounds 1a and 1c are described in
ref. 10, 2a, and 2b in ref. 6, and 3c, 4a, 8b, 8c, 11, 13 and 16 in ref. 7.
Yields refer to the crude product unless otherwise indicated; no
serious attempts were made at optimization.
Complex 4 formation
The general procedure is illustrated with complex 4b
2-Propyl-3-propylimino-9-thioxo-pyrroloquinoline 2a (m.p.
143-144°C)6 (113 mg, 0.36 mmol) was added to 2-aminopropane
(1 mL, large mmol excess) with stirring at room temperature.
After 15 min reaction the mixture was treated with water and
extracted with chloroform. Evaporation of the extract under
reduced pressure and temperature gave a residue of complex 4b
(117 mg, 87%). Needles (from ethyl acetate); (81 mg, melting
with decomposition); δ 0.94(3H, t, J7.4), 1.06(3H, t, J7.3), 1.13(6H,
d, J6.4), 1.7–1.8(4H, m), 3.3(1H, m), 3.77(2H, t, J7.2), 4.5(~2H, br
peak, removed by D2O), 4.54(~3H, t, J7.0), 7.58(1H, m, ArH),
7.73(1H, m, ArH), 8.07(1H, d, J8.2, ArH), 8.75(1H, d, J8.2, ArH).
Volumetric analysis [(as with 4d (vide infra)] established a 1:1
substrate:amine composition.
Complex 4c
Similar treatment of substrate 2a (108 mg, 0.34 mmol) with
diethylamine (1 mL) gave a syrup (125 mg, 0.33 mmol). This
product was repeatedly triturated with cold benzene to provide
a brown gum, soluble in hot hexane which analysed (1H NMR) as
a 1:1 substrate:amine complex; δ 0.91(3H, t, J7.4), 1.06(3H, t, J7.3),
1.27(6H, t, J7.2), 1.59–1.85(4H,m), 3.02(4H, q, J7.2), 3.73(2H, t, J7.3),
4.54(2H, t, J7.0), 5.75(2H, br peak removed by D2O), 7.54(1H, m,
ArH), 7.68(1H, m, ArH), 8.02(1H, d, J8.1, ArH), 8.8(1H, d, J8.2,
ArH).
Complex 4d
Similar treatment of substrate 2a (318 mg, 1.015 mmol) with
triethylamine (1 mL, large mmol excess) provided complex 4d as
a brown gum (423 mg, after extended stay in a vacuum
dessicator; ~100%); δ 0.93(3H, t, J7.4), 1.05(3H, t, J7.3), 1.30(9H, t,
J7.3), 1.64–1.85(4H, m), 3.17(6H, q, J7.3), 3.74(2H, t, J7.2), 4.54(2H,
t, J7.1), 7.5(1H, m, ArH), 7.65(1H, m, ArH), 8.0(1H, d, J8.2, ArH),
8.93(1H, d, J8.3, ArH). Product 4d (415 mg, 1.00 mmol) was
dissolved in methanol (5 mL) to which solution was added
1.00 mL of 2.188 M HCI. Sparingly soluble substrate 2a was
collected by filtration (290 mg, ~93% recovery) after which the
filtrate and washing were combined and titrated (Methyl Red)
with 0.1030 M NaOH which established that 1.10 mmol of
triethylamine had been present, and confirmed a 1:1 complex
composition.
Complex 4e
Similar treatment of substrate 2a (173 mg, 0.55 mmol) and
tert-butylamine (1 mL) gave compound 4e (210 mg, ~100%;
theory for a 1:1 complex: 214 mg). Needles (125 mg; from
hexane), m.p.124–138°C (decomp.); δ 0.95 (3H,t,J7.4), 1.07(3H, t,
J7.4), 1.21(9H, s), 1.65–1.85 (4H, m), 3.78(2H, t, J7.2), 4.45–4.6
(~5H, m, simplifies to 2H, t, J6.8, with D2O), 7.55 (1H, m, ArH),
7.71(1H, m, ArH), 8.04 (1H, d, J8.3, ArH), 8.80(1H, d, J8.4).
4-Thioxoquinoline-propylamine complex
A mixture of 4-thioxoquinoline 5 (142 mg, 0.88 mmol) and
propylamine (1 mL, large mmol excess) was stirred at room
temperature for 10 min and was then evaporated at reduced
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Table 2 Antimicrobial activity of compounds 2, 4, 5, 18 and 19 against
selected pathogens.
Compound S. aureus B. cereus S. epidermidis
DD a MIC b DD MIC DD MIC
2a 8 78 8 c c c
2b 6 d 14 c c c
2c 10 16 c c 13 16
4a 15 19.5 12 12 10 20
4b 14 20 c c 14 39
4c 13 39 c c 12 20
4d 13 <13 e c c 12 <3 e
4e 12 <13 e c c 12 <13 e
4f 10 <13 e 12 31 16 156
5 14 3.8 10 3.8 30 7.6
18a c c c c c c
18b c c c c c c
19a 22 d 18 d d d
19b c d 14 d d d
Ciprofloxacin 22 3.1 33 3.1 d 0.39
DMSO c >400 c >400 c >400
a Disc Diffusion value; diameter of zone inhibition in mm including the 6 mm disc.
b Minimum inhibitory concentration; µg mL–1.
cOrganisms were not inhibited.
d Not determined, especially when antimicrobial activity is lacking in DD test.
e Indicative rather than specific value.
pressure and temperature to constant mass (184 mg, theory:
194 mg for a 1:1 complex). Crystallization of a small portion from
ethyl acetate gave yellow crystals, which decomposed on
warming or on prolonged keeping at room temperature, with
liberation of propylamine (litmus paper). The freshly prepared
complex (184 mg) was dissolved in water (5 mL) containing
1.00 mL of 2.162 M HCI when 4-thioxoquinoline 5 separated as a
gum which solidified and was collected by filtration and identi-
fied from its IR spectrum. The combined filtrate and aqueous
washings was titrated (Methyl Red) with 0.1065 M NaOH from
which volumetric data, 0.88 mmol complex contained 0.83 mmol
propylamine, confirming a 1:1 substrate:amine composition for
the complex.
Formation of complex 4a from 9-chloro-3-propylimino-pyrrolo-
quinoline 11 and propylamine/hydrogen sulphide
Substrate 11 (152 mg, 0.48 mmol) was added portion-wise
(over ~15 min) with stirring to an ice-cold solution (1.5 mL) of
13% (w/w) hydrogen sulphide in propylamine. Stirring was
continued at room temperature overnight. Water and chloro-
form were added and the chloroform extract was evaporated
under reduced pressure and temperature to afford complex 4a
(41 mg, ~23%) identical (IR) with authentic2 complex 4a.
2-Propyl-3a,4,9,9a-tetrahydro-pyrrolo[3,4-b]quinoline-1,3-dione 10
To 2-propyl-9-thioxo-pyrroloquinoline-1,3-dione 6a (150 mg,
0.55 mmol) in absolute EtOH (25 mL) was added highly active
Raney nickel (Across commercial product, stored under water;
ca. 3–5 g), and the stoppered mixture was shaken at room tem-
perature overnight. The reaction was decanted and filtered
(through a thin pad of Celite) and the residual Raney nickel was
washed repeatedly with hot ethanol. The combined filtrate and
washings was evaporated and the residue was treated with
water and chloroform. Evaporation of the chloroform extract
gave S-free product 10 (96 mg, 72%) colouress crystals (from
hexane), m.p. 84–85°C (Found: M+, 244.1223. Calc. for
C14H16N2O2: M, 244.1212) δ 0.56(3H, t, J7.4), 1.36(2H, sextet),
2.9–3.05(2H, m), 3.3–3.5(3H, m), 4.20(1H, d, J9.4), 4.46(1H, br s,




(244 mg, 0.78 mmol) was dissolved with stirring in an excess of
ice-cold ethereal diazomethane (which solution contained
traces of water and ethanol from its preparation). TLC (silica gel,
2% ethanol in benzene) monitoring of the reaction showed
mainly one product (of high Rf) after 1 h. The mixture was
allowed to evaporate in the hood and the residue of compound
8a (220 mg, 86%) was crystallized from hexane; colourless
needless, m.p. 105–106°C (Found: C, 65.80; H, 7.01; N, 12.62; S,
9.52; M+, 327.1407 (100%). Calc. for C18H21N3OS: C, 65.98; H, 6.46;
N, 12.88; S, 9.79; M, 327.1405) δ 0.98(3H, t, J7.4), 1.07(3H, t, J7.3),
1.71–1.88(4H, m), 2.82(3H, s), 3.85(2H, t, J7.2), 4.55(2H, t, J7.0),
7.70(1H, m, ArH), 7.85(1H, m, ArH), 8.20(1H, dd, J1.0, 8.3, ArH),
8.75(1H, dd, J1.2, 8.3, ArH).
(b) Substrate 2a (100 mg, 0.32 mmol) was added with stirring to
ice-cold methyl iodide (4 mL, large mmol excess) followed on
with anhydrous powdered potassium carbonate (~100 mg).
Stirring was continued for ~5 min or until TLC showed the ab-
sence of substrate 2a. After a further 20 min, water was added
and the reaction extracted with chloroform. Evaporation of the
extract gave compound 8a (83 mg, 80%), identical (1H NMR)
with diazomethane product 8a. A NOE experiment revealed,
amongst others, that irradiation of the 9-methylthio singlet at
δ 2.82 enhanced the signal of the 8-H aromatic proton at δ 8.75,
and had no effect on that of the 5-H proton at δ 8.20. Irradiation
of the latter proton confirmed its proximity7 to the alpha-
methylene protons of the 3-propylimino group, and vice versa.
9-Acetylthio-2-propyl-3-propylimino-2, 3-dihydro-pyrrolo[3,4-b]
quinolin-1-one 8d
2-Propyl-3-propylimino-9-thioxo-pyrroloquinoline 2a (63 mg,
0.20 mmol) was dissolved in acetic anhydride (3 mL) containing
pyridine catalyst (2 drops) at room temperature after which was
the reaction was allowed to proceed overnight. Ice-cold aqueous
sodium bicarbonate was added and the mixture was stirred to
hydrolyse the excess acetic anhydride. Extraction with chloro-
form gave crude product 8d (53 mg, 74%). Colourless crystals
(from hexane), m.p. 113–114°C (Found: C,64.10; H,5.68; N,11.68.
Calc. for C19H21N3O2S: C,64.20; H,5.96; N,11.82) δ 0.96(3H, t, J7.4),
1.08(3H, t, J7.4) 1.7–1.9(4H, m), 2.65(3H, s), 3.83(2H, t, J7.3),
4.56(2H, t, J7.0), 7.72(1H, m, ArH), 7.85(1H, m, ArH), 8.27(1H, d,
J8.7, ArH), 8.41(1H, d, J8.3, ArH.
2-Ethyl-3-ethylimino-9-methylthio-2,3-dihydro-pyrrolo[3,4-b]
quinolin-1-one 8e
Substrate 2d (117 mg, 0.41 mmol) with diazomethane (vide su-
pra) gave title compound 8e (112 mg, 91%). Fine needles (from
hexane), m.p. 133–134°C (Found: M+, 299.1103. Calc. for
C16H17N3OS: M, 299.1092) δ 1.30(3H, t, J7.1), 1.42(3H, t, J7.2),
2.83(3H, s), 3.94(2H, q, J7.1), 4.64(2H, q, J7.2), 7.75(1H, m, ArH),




Acid hydrolysis (methanol + aqueous 2M HCl)7 at 50°C, of
9-methylthio-2-propyl-pyrroloquinolin-1-one 8a (140 mg,
0.43 mmol) for 4 h gave compound 12a (85 mg, 70%). Crystals
(from methanol), m.p. 113–114°C (Found: C, 63.13; H, 5.03; N,
9.59; S, 10.38%; M+, 286.0782. Calc. for C15H14N2O2S: C, 62.89; H,
4.93; N, 9.82; S, 11.19%; M, 286.0776) δ 1.0(3H, t, J7.4), 1.8(2H, m),
2.88(3H, s), 3.81(2H, t, J7.3), 7.8 (1H, m, ArH), 7.95 1H, m, ArH),
8.37(1H, d, J8.2, ArH), 8.73(1H, d, J8.4, ArH). Compound 12a was
also obtained (178 mg, 94%) from 2-propyl-9-thioxo-pyrrolo-
quinoline-1,3-dione 6a (180 mg, 0.66 mmol) and methyl iodide/
potassium carbonate as described for 8a.
2-Propyl-9-propylamino-2,3-dihydro-pyrrolo[3,4-b]quinoline-1,3-
dione 12b
Acid hydrolysis of 2-propyl-9-propylamino-3-propyl-
imino-pyrroloquinoline 3a (145 mg, 0.43 mmol) as for 12a gave
product 12b (117 mg, 92%). Crystals (from ethyl acetate-hexane),
m.p. 118–120°C; δ 0.97(3H, t, J7.4), 1.13(3H, t, J7.4), 1.6–1.9(4H, m),
3.69(2H, t, J7.3), 3.93(2H, q, simplified to t, J7.0 by D2O), 7.3(1H, br
peak, overlapping CDCl3 signal, simplified to the latter by D2O),
7.55(1H, m, ArH), 7.75(1H, m, ArH), 8.23(1H, m, ArH).
Formation of dimers 14 and 15
Complex 4a (150 mg, 0.40 mmol) and 4-chloro-2-propyl-
carbamoyl-3-quinolinecarboxylic acid amide 13 (150 mg,
0.43 mmol) were dissolved in ethyl acetate (5 mL) with warming,
after which the solution was allowed to remain at room tempera-
ture for 5 days. The solid which had separated was collected by
filtration (256 mg) and crystallized from ethyl acetate to obtain
(185 mg) a mixture (m.p. 242–245°C) of dimers 14 and 15, as
evidenced from 1H NMR (CDCl3) (vide infra), and HPLC
(isopropyl alcohol-hexane, 10:490, 254 nm) analysis. TLC
[(acetone-benzene, 1:7)] showed the two components with
dimer 14 of slightly higher Rf value. Separation of the two
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dimers was achieved on a silica gel column using acetone (~3%)
in chloroform as eluent.
Formation of dimer 14
Complex 4a (398 mg, 1.07 mmol) in toluene (15 mL ) was heated
to reflux temperature for 30 min in a stream of nitrogen. The
vapours were passed into a solution of 2.277 M hydrochloric
acid. Back-titration with standard sodium hydroxide established
0.96 mmol of propylamine (also identified as N-benzoyl-
propylamine). Evaporation of the reaction gave a mixture
(336 mg) of 2-propyl-3-propylimino-9-thioxo-pyrroloquinoline
2a and dimer 14, The mixture was separated by treatment with
aqueous ammonia and chloroform; evaporation of the chloro-
form extract gave dimer 14 (122 mg, 0.21 mmol) identified from
(1H NMR spectrum and HPLC) comparison with authentic
product (vide infra). The ammoniacal solution was acidified and
extracted with chloroform to give 2-propyl-3-propylimino-
9-thioxo-pyrroloquinoline 2a (206 mg, 61%), identified from its
1H NMR7 spectrum and m.p. By contrast, refluxing 2a in toluene
solution for up to 5 h led to no production of dimer 14.
Synthesis of dimer 14
A solution of 2-propyl-3-propylimino-9-thioxo-pyrroloquinoline
2a (115 mg, 0.37 mmol) and 9-chloro-2-propyl-3-propylimino-
pyrroloquinoline 11 (115 mg, 0.36 mmol) in dry dioxan (10 mL)
containing triethylamine (0.5 mL) was stirred at room tempera-
ture for 2 days (an arbitrary time period). Evaporation gave a
residue to which was added chloroform and water. Evaporation
of the chloroform extract afforded dimer 14 (238 mg, ~100%),
needles (from ethyl acetate), (m.p. 251–253°C), and free of
contaminant dimer 15, as evidenced from TLC (silica gel,
acetone-benzene, 1:7), 1H NMR, and HPLC (isopropyl alcohol-
hexane, 10:490; 254 nm) examination. (Found: M+, 592.2621.
Calc. for C34H36N6O2S: M, 592.2621) δ 0.68(6H, t, J7.4), 1.05(6H, t,
J7.4), 1.50(4H, m), 1.80(4H, m), 3.58 (4H, t, J7.0), 4.54(4H, t, 7.0),
7.63(2H, m, ArH), 7.85(2H, m, ArH), 8.26(2H, dd, 0.8, 8.4, ArH),
8.46(2H, dd, 0.9, 8.5, ArH). Mixture m.p. with dimer 15 (vide infra),
239–242°C.
Synthesis of dimer 15
Similar alkylation of 2-propyl-3-propylimino-9-thioxo-pyrrolo
quinoline 2a (94 mg, 0.30 mmol) with 9-chloro-2-propyl-
3-thioxo-pyrroloquinoline 16 (87 mg, 0.30 mmol) and
triethylamine in dry dioxan (10 mL) gave dimer 15 (177 mg,
~100%); crystals (from ethyl acetate), m.p. 230–232°C, free of
dimer 14, as evidenced from TLC and HPLC (vide supra). (Found:
M+, 567.1780. Calc. for C31H29N5O2S2: M, 567.1763) δ 0.65–
0.75(6H, m), 1.06(3H, t, J7.0), 1.5–1.65(4H, m), 1.75–1.85(2H, m),
3.61(1H, t, J7.2), 3.88(2H, t, J7.0), 4.53(2H, t, J6.0), 7.63–7.75(2H, m,
ArH), 7.8–7.95(2H, m, ArH), 8.2–8.6(4H, m, ArH).
Aminolysis of dimer(s) 14 + 15 with propylamine
A mixture of approx. equimolar amounts of 14 + 15 (vide supra)
(274 mg,~0.47 mmol ) and propylamine (5 mL) was stirred at
room temperature for 1 h or when TLC (acetone-benzene, 1:7)
revealed the absence of dimer substrate. Excess amine was
evaporated under reduced pressure and temperature and the
residue was treated with water and chloroform. Evaporation of
the chloroform extract gave (271 mg) of complex 4a admixed
with 9-propylamino-pyrroloquinoline 3a. The components
were separated using warm ethyl acetate to afford sparingly
soluble complex 4a (153 mg, 0.41 mmol), while evaporation of
the filtrate gave 2-propyl-9-propylamino-3-propylimino-
pyrroloquinoline 3a (112 mg, 0.33 mmol), as was verified from
the appropriate 1H NMR spectra.
Aminolysis of 9-alkythio-substituted pyrrolo[3,4-b]quinoline 8
General procedure: a mixture of the appropriate substrate 8
(generally 0.5 mmol) and amine (3 mL, large mmol excess) was
stirred at room temperature with TLC and/or HPLC (isopropyl
alcohol-hexane, 3:497) monitoring to estimate the end of
reaction (cf. Table 1). The product was isolated by evaporation
of excess amine at reduced temperature (to avoid/minimize
possible7 amine-imine exchange), and was identified by
comparison (IR, mixture m.p) with authentic7,10 product 3. The
respective liberated mercaptan could be detected from its odour
but was not isolated. Table 1 lists the experimental conditions
and outcomes. New 2-Propyl-9-isopropylamino-3-propylimino-2,3-
dihydro-pyrrolo[3,4-b]quinolin-1-one 3b was obtained from sub-
strate 8a and 2-aminopropane (Table 1). Crystals (from aqueous
ethanol), m.p. 77–78°C (Found: C,70.83; H,7.60; N,16.29. Calc. for
C20H26N4O: C,70.97; H,7.74; N,16.56) δ 0.96(3H, t, J7.4), 1.05(3H, t,
J7.4), 1.43(6H, d, J6.3), 1.6–1.85(4H, m), 3.73(2H, t, J7.2), 4.4–
4.6(3H, m), 7.45(1H, m, ArH), 7.6–7.7(2H, m, simplifies to 1H, m,
with D2O), 8.05(1H, d, J8.3, ArH), 8.18(1H, d, J8.6).
9-Methoxy-2-propyl-3-propylimino-2,3-dihydro-pyrrolo(3,4-b)
quinolin-1-one 8f
a) To a solution of sodium (40 mg, 1.7 mmol) in methanol
(2 mL) was added 9-methylthio-pyrroloquinoline 8a (165 mg,
0.50 mmol). The reaction was complete in ~1 h (TLC monitor-
ing). Water was added and the mixture extracted with chloro-
form. Evaporation of the extract gave product 8f (155 mg,
0.50 mmol), crystals (from aqueous ethanol), m.p. 64°C (Found:
C, 69.55; H, 6.59; N, 13.47. Calc. for C18H21N3O2: C,69.43; H,6.80;
N,13.50).
b) 9-Methylthio-compound 8a (600 mg, 1.83 mmol) was
refluxed overnight in methanol (20 mL) containing anhydrous
sodium acetate (2.0 g). Isolation as in a) gave 8f (590 mg, ~100%),
m.p. 63.5-64°C (from aqueous ethanol). In the absence of sodium
acetate no 8f was formed.
c) 9-Chloro-compound 11 (25 mg, 0.071 mmol) was added at
room temperature to a solution of sodium (30 mg, ~1.3 mmol) in
methanol (3 mL). After 1 h at room temperature the reaction mix-
ture was treated as in a) to give 8f, m.p. 63.5–64°C, identical (IR,
mixture m.p., with the products in a) and b).
9-Methoxy-pyrroloquinoline 8f transformations
a) Aminolysis. Treatment of 8f (102 mg, 0.33 mmol) with
propylamine (2 mL, large mmol excess) as for substrates 8 (vide
supra) for 12 h gave 9-propylamino-pyrroloquinoline 3a (118 mg,
0.35 mmol), m.p. 71°C (from ethanol), identical (mixture m.p.
and IR) with the literature7 compound.
b) Thiolysis. Substrate 8f (10 mg, 0.03 mmol) was added to a
solution of sodium (20 mg, 0.9 mmol) in methanol (2 mL)
containing 1-propanethiol (95 mg, 1.2 mmol). TLC monitoring
showed reaction was complete within 20 h at room temperature,
and yielded 9-propylthio-pyrroloquinoline 8b, identical with
authentic7 compound.
c) Hydrolysis. Compound 8g (70.0 mg, mmol) in methanol
(1 mL) and 2M HCl (1 mL) was warmed at ~50°C for 3 h,
followed by cooling, dilution with water and filtration to give
2-propyl-2,3-dihydro-pyrrolo[3,4-b]quinoline-1,3,9-trione 17
(49.0 mg,~93%), m.p. >250°C (Found: C,65.37; H,4.54; N,10.78.
Calc. for C14H12N2O3: C,65.62; H,4.72; N, 10.93). Similar hydroly-
sis of substrate 8f afforded the identical product.
2-Propyl-3-propylimino-9-propoxy-2,3-dihydro-pyrrolo[3,4-b]
quinolin-1-one 8g
To a solution of sodium propoxide [prepared from sodium
(40 mg, 1.7 mmol) and 1-propanol (1 mL)] was added
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9-methylthio-pyrroloquinoline 8a (165 mg, 0.51 mmol). After
~1 h at room temperature? TLC showed only product 8g.
Extraction (water and chloroform) and evaporation of the
extract gave (194 mg, ~100%) 9-propoxy derivative 8g; crystals
(from aqueous ethanol), m.p. 57°C (Found: C,70.81; H,7.07;
N,12.45. Calc. for C20H25N3O2 : C,70.77; H,7.42; N, 12.38) δ 0.97
(3H, t, J7.4), 1.07–1.14 (6H, m), 1.70–1.97(6H, m),3.80 (2H, t, J7.2),
4.53 (2H, t, J7.0), 4.94 (2H, t, J6.4), 7.59–7.62 (1H, m), 7.77 (1H, m),




4.03 mmol) was added in small portions (over a period of
10–15 min) with stirring to ice-cold propylamine (10 mL; large
mmol excess) after which the reaction was continued and
worked up in the standard manner6 to obtain product 4f (0.82 g,
53%). Crystals (from ethyl acetate), m.p. 120–145°C (decomp.)
δ 0.88–0.94 (6H, m), 1.03 (3H, t, J7.3), 1.58–1.82 (6H, m), 2.88(2H, t,
J7.5), 3.71(2H, t, J7.3), 4.48(2H, t, J7.0), 4.9(~3H, br peak), 7.23(1H,
m, ArH), [7.28 (CDC13)], 7.56(1H, dd, J2.6, 10.0, ArH), 8.96(1H, m,
ArH). Volumetric analysis (as for complex 4d) established an
equimolar (2c: amine) composition. From the combined filtrate
and washings was isolated 6-fluoro-2-propyl-9-propylamino-3-
propylimino-2,3-dihydro-pyrrolo[3,4-b]quinolin-1-one 3d.
Crystals (from ethanol), m.p. 76–78 C (175 mg, 12%); δ 0.95(3H, t,
J7.3), 1.04(3H, t, J7.3), 1.12(3H, t, J7.3), 1.7–1.9(6H, m), 3.72(2H, t,
J6.8), 3.80(2H, q, simplifies to t, J6.8, with D2O), 4.47(2H, t, J6.9),
7.20(1H, m, ArH), 7.66(1H, d, J10.1, ArH) 7.90(1H, br peak,
removed by D2O, NH), 8.29(1H, m, ArH).
6-Fluoro-2-propyl-3-propylimino-9-thioxo-2,3-dihydro-pyrrolo[3,4-b]
quinolin-1-one 2c
Complex 4f (168 mg, 0.43 mmol) was added with stirring to
glacial acetic acid (1 mL) at room temperature. After 10 min
reaction water was added dropwise till precipitation of product
2c was complete. This was collected by filtration, washed with
water and dried to yield 135 mg (95%) compound 2c. Crystals
(from ethyl acetate), m.p. 119–122°C (Found: C,61.51; H,5.37;
N,12.55. Calc. for C17H18FN3OS: C,61.61; H,5.47; N,12.68)
δ (CDC13 + DMSO-d6) 0.96(3H, t, J7.4), 1.05(3H, t, J7.4),
1.68(2H, m), 1.85(2H, m), 3.80(2H, t, J7.3), 4.47(2H, t, J7.1),




To a solution of complex 4f (194 mg, 0.50 mmol) in methanol
(5 mL) was added 2M HCl (2 mL). The reaction was kept at 50°C
for 12 h and diluted with water. Product 6b was collected by fil-
tration, washed with water and dried (140 mg; 97%). Crystals
(from methanol), m.p. 210–212°C (Found: C,57.66; H,3.73,
N,9.51. Calc. for C14H11FN2O2S: C 57.92; H,3.82; N,9.65) δ (CDC13
+ DMSO-d6) 0.96(3H, t, J7.4), 1.7(2H, m), 3.63(2H, t, J7.3), 7.26(1H,
m, ArH), [7.85(CDC13)], 7.62(1H, m, ArH), 8.83(1H, m, ArH).
Antimicrobial Activity
Broad-spectrum antimicrobial screening was performed on
the compounds shown in Table 2 using a disc diffusion (DD)
method. From the initial screening a number of these were
identified as having some antimicrobial activity. This activity
was then assessed more quantitatively using a minimum
inhibitory concentration (MIC) procedure.
Disc diffusion studies. Antimicrobial DD assays were performed
on four reference bacterial strains: Escherichia coli (ATCC 11775),
Staphylococcus aureus (ATCC 25923), Stapthylococcus epidermidis
(ATCC 2223) and Bacillus cereus (ATCC 11778). Base layers of
Tryptone Soya (Oxoid) agar were prepared for bacterial cul-
tures. Spore suspensions yielding an inoculum size of approxi-
mately 1 × 106 CFU mL–1 were thoroughly mixed into the over-
laying agar surface. With aseptic manipulation,. 6 mm discs were
saturated with a solution containing the accurately weighed
(8–12 mg) compound dissolved in dimethyl sulphoxide (Merck)
at a starting concentration of 50 mg mL–1 and placed onto the set
agar. Ciprofloxacin discs (1 µg, Oxoid) were used for positive
bacterial controls. All plates were incubated at 37°C for 24 h. Tests
were done in duplicate, and the measured inhibition zones
assigned an arbitrary rating: 7–8 mm = weakly active;
10–12 mm = moderately active; 14–16 mm = good activity.
Microplate bioassay. Minimum inhibitory concentrations (MIC)
were determined on most of the compounds which showed a
positive antimicrobial activity (DD), using the INT microplate
method as described by Eloff14. The respective dimethyl
sulphoxide solutions, at starting concentrations of 1.25 mg mL–1,
were transferred into the first well of a microtitre plate. Serial di-
lutions were performed so that the extract concentrations of
0.625, 0.313, 0.156, 0.078, 0.039, 0.020 and 0.013 mg mL–1 were ob-
tained. A fixed bacterial culture yielding an inoculum size of 1 ×
106 CFU mL–1 was added to all wells and incubated at 37°C for
24 h. An amount of 40 µL of a 0.2 mg mL–1 p-iodonitrotetrazolium
violet (INT) solution was transferred to all inoculated wells and
examined to determine a colour change in relation to concentra-
tion of microbial growth after 6 h. MIC determinations were run
on propylamine, triethylamine and tert-butylamine, respec-
tively, utilizing a MIC microtitre plate covered with a plastic seal
to avoid or at least minimize loss of amine by evaporation. These
amines showed no measurable activities in the DD and MIC
tests.
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